Lv7
5000 积分 2023-02-23 加入
[IL-1β inhibitor sensitizes to olaparib in homologous recombination deficiency proficient ovarian cancer cells]
5个月前
已完结
Preclinical and Phase I Randomized Study of a Potent Inhalable Nanobody Targeting TSLP for the Treatment of Airway Inflammation
8个月前
已完结
Toxicologic Evaluation of Cefamandole Nafate in Laboratory Animals
9个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
9个月前
已完结
TROP2 expression and therapeutic targeting in uterine carcinosarcoma
9个月前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
9个月前
已完结
皖公网安备34019202002308
